circle with rainbow colors


2022 Life sciences regulatory outlook

Navigating key trends in life sciences regulatory compliance

Gain industry insight into key regulations and get updates on what companies should be tracking and addressing in 2022 and beyond.


2021 Life sciences regulatory outlook

Over the past several years, life sciences companies have faced mounting pressure from many directions, including increasing regulatory requirements, nonstop technological advances, and intense pricing pressure. And the unprecedented events in recent years have only provided more reason to modernize compliance and elevate the value and partnerships within your companies and external stakeholders.

To continue thriving and leading, life sciences companies must continue to meet the industry’s new challenges head-on. Now is the ideal time for the compliance function to evolve its focus from hindsight to foresight.

In the 2021 regulatory outlook, the overarching theme was for life sciences companies to take a closer look at their compliance activities. Download the report to see how companies can make compliance an integral part of their overall business strategy.

More life sciences trends and insights

  • Read Deloitte's 2021 global life sciences outlook for insights on how life sciences companies continue to respond to the impacts of the pandemic and in what areas they can build resilience going forward

Get in touch

Paul Silver
Deloitte & Touche LLP
+1 404 631 215

Jack Tanselle
Managing director
Deloitte & Touche LLP
+1 317 656 2452

Marcy Imada
Managing director
Deloitte & Touche LLP
+ 1 213 553 1642

Clarissa Crain
Managing director
Deloitte & Touche LLP
+1 717 669 6090

Fullwidth SCC. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.